Table 3 Univariable logistic regression for the composite endpoint of an unfavorable postoperative outcome in the retrospective cohort.
Variable | Composite endpoint | |
---|---|---|
OR [95% CI] | p-value | |
Clinical characteristics | ||
Age, years | 1.001 [0.987–1.015] | 0.908 |
eGFR, ml/min | 0.996 [0.990–1.001] | 0.109 |
Hematocrit, % | 0.968 [0.936–1.001] | 0.059 |
NYHA > II | 0.965 [0.661–1.407] | 0.852 |
Pulmonary hypertension* | 1.689 [0.990–2.880] | 0.054 |
Significant tricuspid regurgitation (grade ≥ 2) | 2.414 [1.340–4.350] | 0.003 |
Urgent/emergency procedure | 1.039 [0.671–1.610] | 0.862 |
3D LV echocardiographic parameters | ||
LVEDVi, ml/m² | 1.008 [1.002–1.014] | 0.011 |
LVESVi, ml/m² | 1.012 [1.004–1.019] | 0.002 |
LVEF, % | 0.978 [0.963–0.992] | 0.003 |
LV GLS, % | 1.037 [1.002–1.074] | 0.040 |
2D RV speckle-tracking echocardiography | ||
2D RV FWLS, % | 1.032 [1.008–1.057] | 0.010 |
2D RV GLS, % | 1.067 [1.032–1.104] | < 0.001 |
ReVISION-derived 3D RV parameters | ||
RVEDVi, ml/m² | 1.003 [0.995–1.012] | 0.402 |
RVESVi, ml/m² | 1.012 [1.001–1.022] | 0.034 |
RVEF, % | 0.962 [0.942–0.982] | < 0.001 |
RV GLS, % | 1.105 [1.059–1.153] | < 0.001 |
RV GCS, % | 1.040 [1.003–1.078] | 0.033 |
RV GAS, % | 1.054 [1.026–1.083] | < 0.001 |
LEF, % | 0.928 [0.896–0.962] | < 0.001 |
LEF/RVEF | 0.205 [0.040–1.052] | 0.058 |
AEF, % | 0.948 [0.918–0.980] | 0.001 |
AEF/RVEF | 0.424 [0.078–2.308] | 0.321 |
REF, % | 0.981 [0.959–1.005] | 0.117 |
REF/RVEF | 1.036 [0.331–3.237] | 0.952 |